Sector ratings argenx SE

Equities

Market Closed - Euronext Bruxelles Other stock markets 16:55:00 22/04/2026 BST			5-day change	1st Jan Change
678.40 ^EUR	-1.17%		-4.45%	-5.36%

04-21	European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading	MT
04-18	Argenx SE Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ARGENX SE	50.17B		A
WUXI APPTEC CO., LTD.	43.62B		AAA
INSMED INCORPORATED	30.43B	-	A	-		-
BIONTECH SE	28.22B	-	-	-		-
SUMMIT THERAPEUTICS INC.	20.45B	-	-	-		-
WUXI BIOLOGICS (CAYMAN) INC.	18.65B		AAA
AKESO, INC.	17.26B		B			-
GENMAB A/S	16.71B		A
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	14.9B	-	AA	-		-
MADRIGAL PHARMACEUTICALS, INC.	12.11B	-	B	-		-
EXELIXIS, INC.	11.66B		BB
REMEGEN CO., LTD.	10.44B		-
ARROWHEAD PHARMACEUTICALS, INC.	9.95B	-	BB	-		-
SAMSUNG EPIS HOLDINGS CO., LTD.	9.64B		-				-
VAXCYTE, INC.	8.71B	-	BBB	-		-
NUVALENT, INC.	8.42B	-	CCC	-		-
IMMUNITYBIO, INC.	8.37B	-	CCC	-		-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
CYTOKINETICS, INCORPORATED	8.1B	-	AA	-		-
PHARMAESSENTIA CORPORATION	7.66B		AA
Average	17.18B		A
Weighted average by Cap.			A